EAGAN, Minn.--(BUSINESS WIRE)--New data demonstrates that Biothera’s immunotherapy drug candidate inhibits a cancer defense mechanism that recruits and polarizes certain immune cells for its own protection and growth. The in vitro research will be presented tomorrow at the Society for Immunotherapy of Cancer (SITC) in National Harbor, MD.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
